LHCCX
Price
$16.72
Change
-$0.07 (-0.42%)
Updated
May 22 closing price
Net Assets
7.26M
SHSAX
Price
$59.51
Change
-$0.42 (-0.70%)
Updated
May 22 closing price
Net Assets
6.58B
Interact to see
Advertisement

LHCCX vs SHSAX

Header iconLHCCX vs SHSAX Comparison
Open Charts LHCCX vs SHSAXBanner chart's image
Lord Abbett Health Care C
Price$16.72
Change-$0.07 (-0.42%)
VolumeN/A
Net Assets7.26M
BlackRock Health Sciences Opps Inv A
Price$59.51
Change-$0.42 (-0.70%)
VolumeN/A
Net Assets6.58B
LHCCX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LHCCX vs. SHSAX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LHCCX is a Hold and SHSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.58B vs. LHCCX (7.26M). SHSAX pays higher dividends than LHCCX: SHSAX (0.22) vs LHCCX (0.00). LHCCX was incepted earlier than SHSAX: LHCCX (6 years) vs SHSAX (25 years). LHCCX (4.09) is less costly to investors than SHSAX (1.09). LHCCX is a more actively managed with annual turnover of: 88.00 vs. SHSAX (27.00). SHSAX has a lower initial minimum investment than LHCCX: SHSAX (1000) vs LHCCX (1500). LHCCX annual gain was more profitable for investors over the last year : -7.78 vs. SHSAX (-13.43). LHCCX return over 5 years is better than : -0.06 vs. SHSAX (-6.46).
LHCCXSHSAXLHCCX / SHSAX
Total Expense Ratio1.781.09163%
Annual Report Gross Expense Ratio4.091.09375%
Fund Existence6 years25 years-
Gain YTD-7.283-2.018361%
Front LoadN/A5%-
Min. Initial Investment15001000150%
Min. Initial Investment IRAN/AN/A-
Net Assets7.26M6.58B0%
Annual Yield % from dividends0.000.22-
Returns for 1 year-7.78-13.4358%
Returns for 3 years6.89-7.51-92%
Returns for 5 years-0.06-6.461%
Returns for 10 yearsN/A10.60-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVIX24.53N/A
N/A
JHancock Classic Value I
GTSRX22.61N/A
N/A
Invesco Small Cap Growth R
EMQCX8.16N/A
N/A
Ashmore Emerging Markets Active Eq C
FECMX40.70N/A
N/A
Fidelity Advisor Emerging Markets I
TSCGX16.89-0.47
-2.71%
Thrivent Small Cap Growth S